Sulfasalazine
Last updated: 17/08/2023
(Also known as: salicylazosulfapyridine; sulphasalazine)
The following alerts are based on the data in the tables below. An absence of an alert does not imply the substance has no implications for human health, biodiversity or the environment but just that we do not have the data to form a judgement.
Environmental fate
Ecotoxicity
Human health
 
 
A widely used human and veterinary drug used to treat rheumatoid arthritis, inflammatory bowl disease, colitis & Crohn's disease
Current
-
Dogs; Cats
-
C₁₈H₁₄N₄O₅S
C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
No data
OQANPHBRHBJGNZ-UHFFFAOYSA-N
InChI=1S/C18H14N4O5S/c23-16-9-6-13(11-15(16)18(24)25)21-20-12-4-7-14(8-5-12)28(26,27)22-17-3-1-2-10-19-17/h1-11,20H,(H,19,22)(H,24,25)
Yes
Cambridge Crystallographic Data Centre diagrams
Common Name
Relationship
Link
sulfasalazine
-
Medicinal drug: anti-bacterial; anti-inflammatory
Aminosalicylate
-
-
Synthetic
Works by reducing the production of chemicals that mediate inflammation such as inflammatory cytokines and eicosanoids.
[Arachidonate 5-lipoxygenase, Inhibitor], [Prostaglandin G/H synthase 2, Inhibitor], [Prostaglandin G/H synthase 1, Inhibitor], [Peroxisome proliferator-activated receptor gamma, Agonist], [Inhibitor of nuclear factor kappa-B kinase subunit alpha, Inhibitor], [Inhibitor of nuclear factor kappa-B kinase subunit beta, Inhibitor], [Cystine/glutamate transporter, Inhibitor]
599-79-1
209-974-3
-
-
-
QA07EC01
Intestinal antiinflammatory agents: Aminosalicylic acid and similar agents
No
-
398.39
2-hydroxy-5-((E)-2-(4-((pyridin-2-yl)sulfamoyl)phenyl)diazen-1-yl)benzoic acid
2-hydroxy-5-((E)-2-(4-((pyridin-2-yl)sulfamoyl)phenyl)diazen-1-yl)benzoic acid
5-((para-(2-pyridylsulfamoyl)phenyl)azo)-salicylic acid
-
-
Brown to orange coloured powder
Salazopyrin
Pharmacia
No approved directly for animals - used under the 'prescribing cascade'
-
-
-
-
-
-
-
-
Decomposes on melting
-
-
-
-
220
-
-
-
-
3.16 X 1002
Calculated
-
2.5
Low
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Soil adsorption and mobility
-
-
-
-
-
-
-
-
Known soil and groundwater metabolites
None
5-aminosalicylic acid Note: Active substance
-
Colonic
-
-
Terrestrial ecotoxicology
15600
Rat
Low
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
HUMAN HEALTH AND PROTECTION
-
-
-
15600
Rat
Low
-
-
-
-
-
-
Intravenous LD₅₀ = 1096 mg kg⁻¹
Mouse
-
Subcutaneous LD₅₀ = 3000 mg kg⁻¹
Mouse
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Carcinogen
Endocrine disruptor
?Possibly, status not identified
A0 A = Chromosome aberration (EFSA database) 0 = No data
; B0 B = DNA damage/repair (EFSA database) 0 = No data
; C0 C = Gene mutation (EFSA database) 0 = No data
; D0 D = Genome mutation (EFSA database) 0 = No data
; E2 E = Unspecified genotoxicity type (miscellaneous data source) 2 = Mixed/ambiguous results
No data found
Reproduction / development effects
Acetyl cholinesterase inhibitor
Neurotoxicant
No data found
No data found
No data found
Respiratory tract irritant
Skin irritant
Skin sensitiser
No data found
No data found
No data found
Eye irritant
Phototoxicant
 
No data found
No data found
 
May cause vomiting, loss of appetite and jaundice May cause dry eyes Studies suggest substance may act as a co-carcinogen
Will emit toxic gases when heated to decomposition
-
Not listed (Not listed)
-
-
-
sulfasalazine
sulfasalazine
Sulfasalazin
-
-
sulfasalazina
-
-
-
-
-
-
Record last updated:
17/08/2023
Contact:
aeru@herts.ac.uk
Please cite as:
Lewis, K.A., Tzilivakis, J., Warner, D. and Green, A. (2016) An international database for pesticide risk assessments and management. Human and Ecological Risk Assessment: An International Journal , 22 (4), 1050-1064. DOI: 10.1080/10807039.2015.1133242